Quality of life (QoL) in patients with metastatic breast cancer (MBC) treated with capecitabine – second interim analysis of the German non-interventional study (NIS).

Steffens, C., Zaiss, Lerchenmüller, C., Luhn, B., Vehling-Kaiser, U., Marschner, N., Hurst, U., Mueller, V., 2012.

J Cancer Res Clin Oncol 138(Suppl.1)(0085), 67. doi:10.1007/s00432-011-1144-4

Studie: Xeloda-NIS; Indikation: Mammakarzinom; Jahr: 2012; Veranstaltung: DKK; Journal: Journal of Cancer Research and Clinical Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com